1. Home
  2. ATNM vs BGFV Comparison

ATNM vs BGFV Comparison

Compare ATNM & BGFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATNM
  • BGFV
  • Stock Information
  • Founded
  • ATNM 2000
  • BGFV 1955
  • Country
  • ATNM United States
  • BGFV United States
  • Employees
  • ATNM N/A
  • BGFV N/A
  • Industry
  • ATNM Biotechnology: Pharmaceutical Preparations
  • BGFV Other Specialty Stores
  • Sector
  • ATNM Health Care
  • BGFV Consumer Discretionary
  • Exchange
  • ATNM Nasdaq
  • BGFV Nasdaq
  • Market Cap
  • ATNM 56.5M
  • BGFV 47.2M
  • IPO Year
  • ATNM N/A
  • BGFV N/A
  • Fundamental
  • Price
  • ATNM $1.40
  • BGFV $1.68
  • Analyst Decision
  • ATNM Strong Buy
  • BGFV
  • Analyst Count
  • ATNM 4
  • BGFV 0
  • Target Price
  • ATNM $8.75
  • BGFV N/A
  • AVG Volume (30 Days)
  • ATNM 342.1K
  • BGFV 297.8K
  • Earning Date
  • ATNM 11-14-2024
  • BGFV 02-25-2025
  • Dividend Yield
  • ATNM N/A
  • BGFV 5.95%
  • EPS Growth
  • ATNM N/A
  • BGFV N/A
  • EPS
  • ATNM N/A
  • BGFV N/A
  • Revenue
  • ATNM $81,000.00
  • BGFV $810,199,000.00
  • Revenue This Year
  • ATNM $138.42
  • BGFV $2.65
  • Revenue Next Year
  • ATNM $19,479.88
  • BGFV N/A
  • P/E Ratio
  • ATNM N/A
  • BGFV N/A
  • Revenue Growth
  • ATNM N/A
  • BGFV N/A
  • 52 Week Low
  • ATNM $1.10
  • BGFV $1.45
  • 52 Week High
  • ATNM $10.24
  • BGFV $5.63
  • Technical
  • Relative Strength Index (RSI)
  • ATNM 56.03
  • BGFV 44.56
  • Support Level
  • ATNM $1.18
  • BGFV $1.63
  • Resistance Level
  • ATNM $1.48
  • BGFV $1.95
  • Average True Range (ATR)
  • ATNM 0.10
  • BGFV 0.10
  • MACD
  • ATNM 0.01
  • BGFV -0.02
  • Stochastic Oscillator
  • ATNM 75.00
  • BGFV 15.62

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About BGFV Big 5 Sporting Goods Corporation

Big 5 Sporting Goods Corp is a specialty retailer company that is principally engaged in the sale of sporting goods in the Western United States. Its product mix includes athletic shoes, apparel, and accessories, as well as a broad selection of outdoor and athletic equipment for team sports, fitness, camping, hunting, fishing, tennis, golf, winter and summer recreation and roller sports. The company operates solely as a sporting goods retailer, which includes both its retail stores and an e-commerce platform. The company operates a distribution center located in Riverside, California, that services all of its stores and e-commerce platform.

Share on Social Networks: